Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2004
06/24/2004CA2507573A1 Nucleic acid labeling compounds
06/24/2004CA2507156A1 Methods of therapy and diagnosis using targeting of cells that express lax
06/24/2004CA2502015A1 5' cpg nucleic acids and methods of use
06/23/2004EP1431390A1 Sample processing device and sample processing method
06/23/2004EP1431312A1 Method for production and a composition for immobilising biological macromolecules in hydrogels and the use of said composition for producing biochips
06/23/2004EP1431303A2 Composition for linear isothermal amplification of polynucleotide sequences
06/23/2004EP1431298A1 Mannitol and glucitol derivatives
06/23/2004EP1431297A1 Mannitol and glucitol derivatives
06/23/2004EP1430157A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
06/23/2004EP1430152A2 Gene and protein relating to hepatocellular carcinoma
06/23/2004EP1430147A1 Fluorescent quenching detection reagents and methods
06/23/2004EP1430132A2 Methods of using 33751, a human potassium channel family member
06/23/2004EP1430118A2 A gene encoding cyclododecanone monooxygenase
06/23/2004EP1430072A2 Antisense modulation of cholesteryl ester transfer protein expression
06/23/2004EP1430070A2 Novel clark protein and nucleic acid molecules and uses therefor
06/23/2004EP1356115A4 Methods for detection of chloral hydrate in dichloroacetic acid
06/23/2004EP1315410A4 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase
06/23/2004EP1180112A4 Detection using degradation of a tagged sequence
06/23/2004EP0796346A4 Nucleic acid sequence detection employing amplification probes
06/23/2004CN1506471A Nuclein detecting method
06/23/2004CN1506467A SCAR marker linked with the acidic character of peach fruit and its application
06/23/2004CN1154747C Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretrioviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
06/23/2004CN1154731C Gene of hop latent virus and methods for detecting the same
06/23/2004CN1154729C Staphylokinase derivs
06/23/2004CN1154727C Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner
06/22/2004US6753423 For preferentially modulated gene expression in liver and associated tissues
06/22/2004US6753309 Nucleosides for imaging and treatment applications
06/22/2004US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor
06/17/2004WO2004051218A2 Multiplex amplification of polynucleotides
06/17/2004WO2004050900A2 Compositions, splice variants and methods relating to colon specific genes and proteins
06/17/2004WO2004050899A2 Method for in vitro selection of 2’-substituted nucleic acids
06/17/2004WO2004018497A3 Modified nucleotides for polynucleotide sequencing
06/17/2004WO2003102138A3 Elongase genes and uses thereof
06/17/2004WO2003058199A3 Arrays of microparticles and methods of preparation thereof
06/17/2004US20040117869 Comprises nucleotide sequences coding oxidoreductase for use in increasing nornicotine biosynthesis in plants
06/17/2004US20040116689 can comprise DNA, RNA, PNA, or any combination or chimera thereof
06/17/2004US20040116687 oligonucleotides having reduced internucleotide charge and enhanced nuclease resistance
06/17/2004US20040116685 Method for solution phase synthesis of oligonucleotides
06/17/2004US20040116680 Photolabile protective groups for the synthesis of biopolymers
06/17/2004US20040116667 Tyrosinase-related gene (TRP2) protein comprising human leukocyte antigen cytotoxic binding recognition points for identifying modulators for diagnosis, prevention and treatment of cancer ; immunotherapy
06/17/2004US20040116366 Antisense modulation of protein phosphatase 2 catalytic subunit beta expression
06/17/2004US20040116365 Modulation of Lck expression
06/17/2004US20040115773 Serpin in bifidobacteria
06/17/2004US20040115716 Identifying oligonucleotide subsequences associated with gene exprssion inhibition
06/17/2004US20040115706 by detecting a fluorescent signal; for drug screening; solid phase synthesis
06/17/2004US20040115696 Utilizing programmable functionalized self-assembling nucleic acids as building blocks for molecular electronic and photonic mechanisms, organizing interconnected nanostructures and/or micronized components of micro or optoelectronic devices
06/17/2004US20040115694 Methods and compositions for determining the sequence of nucleic acid molecules
06/17/2004US20040115693 Novel human kinase proteins and polynucleotides encoding the same
06/17/2004US20040115691 Mutants of enzymes and methods for their use
06/17/2004US20040115687 Comprise matrix polypeptide for diagnosis, treatment, and prevention of immunological, nervous system, developmental, connective tissue and cell proliferative disorders
06/17/2004US20040115676 G-protein coupled receptors
06/17/2004US20040115668 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3
06/17/2004US20040115665 Method for base sequencing and biologically active nucleic acids
06/17/2004US20040115661 Shuttle vector for use as stable gene transfer tool in genetic engineering
06/17/2004US20040115653 Modulation of endothelial lipase expression
06/17/2004US20040115652 Antisense oligonucleotides for controlling expression of receptor tyrosine kinase gene and treatment of hyperproliferative disorders; gene expression inhibition
06/17/2004US20040115651 Modulation of BUB3 expression
06/17/2004US20040115650 Modulation of MAD1-like 1 expression
06/17/2004US20040115649 Modulation of ABCC5 expression
06/17/2004US20040115644 Identifying restriction fragment length polymorphisms via isothermal complexity reduction and nucleotide sequence amplification: genotyping and resequencing
06/17/2004US20040115637 Antisense oligonucleotides for controlling expression of peroxisome proliferator-activated receptor alpha and treatment of hyperproliferative disorders; gene expression inhibition
06/17/2004US20040115636 Modulation of interleukin 18 expression
06/17/2004US20040115634 Antisense oligonucleotides for controlling expression of signal transducers and activators of transcription-6 (STAT-6) genes and treatment of autoimmune disorders; gene expression inhibition
06/17/2004CA2506748A1 Method for in vitro selection of 2'-substituted nucleic acids
06/16/2004EP1428892A1 Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation
06/16/2004EP1428887A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
06/16/2004EP1428810A2 Libraries of oligomers labelled with different tags
06/16/2004EP1427852A2 Single nucleotide amplification and detection by polymerase
06/16/2004EP1427757A1 Late gestation lung genes, fragments and uses thereof
06/16/2004EP1427750A1 Modified transferrin fusion proteins
06/16/2004EP1427747A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
06/16/2004EP1427710A2 Method for the production of cna
06/16/2004EP1119578B1 Improved process for oligonucleotide synthesis
06/16/2004EP0672133B1 TNF-alpha RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-alpha RIBOZYMES
06/16/2004CN1504481A Apoptosis promoting gene BNIPL, coding albumen and uses thereof
06/16/2004CN1504477A Chicken polydactyly functional gene and uses thereof
06/16/2004CN1504476A Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof
06/16/2004CN1504475A Polynucleotide for identifying polypeptide OT10 and coding OT10 of tumor cell and uses thereof
06/16/2004CN1153854C Ferro-nickel alloy electroplating process for copper plate working surface of continuously casting crystallizer
06/15/2004US6750335 Nucleoside for use in the generation of preferential oligonuceotides
06/15/2004US6750024 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
06/15/2004US6750020 Method for alteration detection
06/15/2004US6750019 Antisense modulation of insulin-like growth factor binding protein 5 expression
06/15/2004US6750016 Nanoparticles having oligonucleotides attached thereto and uses therefor
06/15/2004CA2285921C Composition and method for treatment of cmv infections
06/10/2004WO2004049274A2 2’-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same
06/10/2004WO2004048938A2 Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
06/10/2004WO2004048925A2 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION
06/10/2004WO2004048595A2 Vascular-preferred promoters
06/10/2004WO2004048591A2 Methods for cohort selection and longevity studies
06/10/2004WO2004048570A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR
06/10/2004WO2004048564A1 Device for pretreating specimen
06/10/2004WO2004048546A2 Methods for identifying risk of breast cancer and treatments thereof
06/10/2004WO2004048524A2 Modulation of stat2 expression
06/10/2004WO2004048522A2 Modulation of huntingtin interacting protein 2 expression
06/10/2004WO2004048511A2 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
06/10/2004WO2004048451A2 Optical information carrier comprising immobilized proteorhodopsin
06/10/2004WO2004048398A1 Method and apparatus for concentration and purification of nucleic acid
06/10/2004WO2004048397A2 Detectable labeled nucleoside analogs and methods of use thereof
06/10/2004WO2004048376A1 Bicyclic naphthylidine nucleosides